These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34624942)

  • 41. High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma.
    Wang L; Wang X; Sun N; Liu W
    Int Immunopharmacol; 2024 May; 133():112039. PubMed ID: 38613884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary supplementation with pioglitazone hydrochloride and chromium methionine manipulates lipid metabolism with related genes to improve the intramuscular fat and fatty acid profile of yellow-feathered chickens.
    Jin CL; Zeng HR; Gao CQ; Yan HC; Tan HZ; Wang XQ
    J Sci Food Agric; 2020 Feb; 100(3):1311-1319. PubMed ID: 31742693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
    Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M
    Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of peroxisome proliferators-activated receptor-gamma in the chemical prevention therapy of sulindac for precancerous lesions of rats].
    Zhang YP; Lv YM; Li J; Han YJ; Jin Z; Li CF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):168-73. PubMed ID: 19377624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of endothelin-1 stimulation on peroxisome proliferator-activated receptor-gamma expression in vascular smooth muscle cells].
    Di ZL; Niu XL; Wei J; Gao DF; Wang NP
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1140-4. PubMed ID: 16174582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor.
    Wan H; Yuan Y; Liu J; Chen G
    Transl Res; 2012 Aug; 160(2):153-61. PubMed ID: 22677361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet.
    Uto H; Nakanishi C; Ido A; Hasuike S; Kusumoto K; Abe H; Numata M; Nagata K; Hayashi K; Tsubouchi H
    Hepatol Res; 2005 Aug; 32(4):235-42. PubMed ID: 16085455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antagonistic effect of 12-lipoxygenase inhibitor ML355 on lipopolysaccharide induced inflammatory response in mice].
    Wang X; Tang W; Chen T; Luo L; Liang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1378-1384. PubMed ID: 33463501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway.
    Liu Y; Qu Y; Liu L; Zhao H; Ma H; Si M; Cheng L; Nie L
    Int Immunopharmacol; 2019 Jul; 72():138-147. PubMed ID: 30981079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pioglitazone Prevents Hemorrhagic Infarction After Transient Focal Ischemia in Type 2 Diabetes.
    Hasegawa H; Yatomi K; Mitome-Mishima Y; Miyamoto N; Tanaka R; Oishi H; Arai H; Hattori N; Urabe T
    Neurosci Res; 2021 Sep; 170():314-321. PubMed ID: 33309864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of PPAR-gamma in human hilar bile duct carcinoma cell line QBC939 and the effects of PPAR-Y activated by its ligand on the growth of QBC939].
    Cheng W; Cheng NS; Xiong XZ; Xia QJ; Chen OY; Yan NH; Jing J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):745-9. PubMed ID: 17037742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.
    Swanson C; Emborg M
    Neurol Res; 2014 Jul; 36(7):634-46. PubMed ID: 24620964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of pioglitazone mediated activation of PPAR-γ on CIDEC and obesity related changes in mice.
    Shamsi BH; Ma C; Naqvi S; Xiao Y
    PLoS One; 2014; 9(9):e106992. PubMed ID: 25210844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.
    Hu Y; Tao R; Chen L; Xiong Y; Xue H; Hu L; Yan C; Xie X; Lin Z; Panayi AC; Mi B; Liu G
    J Nanobiotechnology; 2021 May; 19(1):150. PubMed ID: 34020670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
    Emery MN; Leontiou C; Bonner SE; Merulli C; Nanzer AM; Musat M; Galloway M; Powell M; Nikookam K; Korbonits M; Grossman AB
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):389-95. PubMed ID: 16918962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peroxisome proliferator activated receptor gamma (PPAR-γ) ligand pioglitazone regulated gene networks in term human primary trophoblast cells.
    El Dairi R; Huuskonen P; Pasanen M; Rysä J
    Reprod Toxicol; 2018 Oct; 81():99-107. PubMed ID: 30031879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
    Benigni A; Zoja C; Tomasoni S; Campana M; Corna D; Zanchi C; Gagliardini E; Garofano E; Rottoli D; Ito T; Remuzzi G
    J Am Soc Nephrol; 2006 Jun; 17(6):1624-32. PubMed ID: 16687628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice.
    Li Y; Xia T; Li R; Tse G; Liu T; Li G
    Med Sci Monit; 2019 Mar; 25():1582-1589. PubMed ID: 30820023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPAR-
    Zhu Y; Ni Y; Liu R; Hou M; Yang B; Song J; Sun H; Xu Z; Ji M
    J Immunol Res; 2018; 2018():6398078. PubMed ID: 30116754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.